Shamonda Virus: First Confirmed Human Infection

24 Oct 2026

Tags: Social Justice   Social Services   Health sector issues

Source: The Indian Express

Context: France confirmed the first known human infection of Shamonda virus (SHAV) in a patient who died at a hospital in Lyon in October 2026.

• Limited public health risk: French health authorities described it as an exceptional case involving a severely immunocompromised patient and stated that no risk to the general public had been identified.

About Shamonda Virus

• Classification: A vector-borne virus belonging to the genus Orthobunyavirus, family Peribunyaviridae, and the Simbu group of viruses.
• Discovery and distribution: First isolated from cattle in Nigeria in 1965; subsequently detected in parts of Africa, Asia and Europe.
• Transmission: Primarily transmitted through bites of infected Culicoides midges, which are small, fly-like blood-feeding insects.
• Affected animals: Mainly infects cattle, but cases have also been reported in sheep, goats, horses and alpacas.
• Symptoms in animals: Fever, diarrhoea, reduced milk production and reproductive disorders; neurological symptoms are less common. Laboratory testing is necessary because symptoms resemble those of other livestock diseases.

Recent Outbreaks in Europe

• Circulating variants: According to the World Organisation for Animal Health (WOAH), two variants have caused European outbreaks in 2026: Shamonda virus Europe 1 (SHAV-EU1) and Shamonda virus Europe 2 (SHAV-EU2).
• Seasonal transmission: Outbreaks of Simbu-group viruses often follow cyclical patterns linked to the seasonal activity of Culicoides midges.
• Uncertain impact: The long-term consequences in Europe remain unclear, particularly because European variants may behave differently in previously unexposed cattle populations.

First Human Case: Clinical Findings

• Patient profile: A leukaemia patient in their sixties, with severely compromised immunity, developed blindness, confusion and subsequently fell into a coma.
• Diagnosis: Doctors detected genetic markers of Shamonda virus in the patient's cerebrospinal fluid (CSF).
• Genomic confirmation: Following the patient's death, whole-genome sequencing of brain tissue samples confirmed infection with the SHAV-EU1 variant.
• Likely source: The infection was believed to have resulted from a midge bite in eastern France, where the virus circulated among animals during spring and summer.

Prevention and Control Measures

According to WOAH, no commercially available vaccine against Shamonda virus currently exists. Recommended preventive measures include:

• Physical barriers: Installing fine-mesh screens and double-door entry-exit systems to prevent midges from entering animal shelters.
• Vector control: Eliminating potential breeding sites and strengthening surveillance and control of midges around buildings.
• Safe animal transportation: Moving livestock during periods of low vector activity to minimise exposure and transmission.

Important Concepts for UPSC

• Vector-borne diseases: Infectious diseases transmitted through living organisms such as mosquitoes, ticks and midges. Examples include malaria (mosquitoes), scrub typhus (chigger mites) and Shamonda virus infection (midges).
• Zoonotic diseases: Infections naturally transmissible between vertebrate animals and humans. The first reported human Shamonda infection highlights the need to investigate its potential zoonotic significance, although its human transmission dynamics remain poorly understood.
• One Health approach: An integrated framework recognising the interdependence of human, animal and ecosystem health. It emphasises coordinated disease surveillance and prevention across medical, veterinary and environmental sectors.
• World Organisation for Animal Health (WOAH): An intergovernmental organisation established in 1924, headquartered in Paris, France. Formerly known as the Office International des Epizooties (OIE), it develops international standards for animal health and promotes the prevention and control of animal diseases.